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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S89complete. Furthermore, about 30% of OA samples (hip and knee) showed
a fragment of approximately 20KDa that it's not present in none of the 18
control samples analyzed. This fragment seems not to be speciﬁc of
MMP13 since it was present before the incubation with the protease, and
the intensity of the band did not increase with the in vitro MMP-13
digestion.
Conclusions: We found three ECM proteins susceptible of MMP13 diges-
tion that could be potential OA biomarkers. Interestingly, results showed
that 30% of OA patients had a MMP13 not speciﬁc fragment from OGN. The
presence or absence of this fragment could be useful as a tool to identify
a group of patients with similar characteristics
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ANALYSIS OF THE SERUM BIOMARKERS IN HUMAN KNEE
OSTEOARTHRITIS
C. Daozhang, C. Yuxian, Z. Hua. The third afﬁliated Hosp. of Sun Yat-Sen
Univ., guangzhou, China
Purpose: Osteoarthritis (OA) is characterized by a degeneration of carti-
lage whose main clinical symptoms are pain, deformity and loss of func-
tion.With the coming of global aging society, OA has become a leading
cause of disability in the elderly.Its poorly understood pathogenesis limits
the discovery of targets for pharmacological intervention and there are few
effective medical treatments beyond pain control and surgery. Effective
method of early diagnosis and treatment of OA are desperately needed.
To search proteins that might serve as serum biomarkers for OA diagnosis,
treatment or pathogenesis, this study preformed technologies to identify
differentially expressed proteins from serum obtained from patients with
knee osteoarthritis(OA) and controls.
Methods: There are 4 subjects of OA and 4 age- and sex- matched normal
adults involved in the study, 4 subjects of OA are randomly selected from30
patients diagnosed with primary knee osteoarthritis. Serum samples from
each subject were treated with ProteoExtract Albumin/IgG Removal Kit
and Clean-up Kit, then cross-labeled with different CyDye, followed by two
dimension difference in gel electrophoresis(2D-DIGE), map scanning, and
then themaps of protein spots were compared using the software DeCyder
v6.0 to ﬁnd out the different expressed proteins. Treat these proteins with
Matrix assisted laser desorption ionization-time of ﬂight mass spec-
trometry(MALDI-TOF-MS), and get peptide ﬁnger printing maps(FPM),
then search themwithMASCOT in Swiss-Prot/Uniprot date base to identify
these proteins. Finally, use bioinformatics to analysis biological functions
and research value of these proteins.
Results: We found 14 differentially expressed protein spots compared
serum samples from patients with OA relative to the controls. The MS
revealed 14 proteins that alpha-2-macroglobulin, gelsolin, vitamin K-
dependent protein S, kininogen-1, complement C3 were increased, and
haptoglobin, inter-alpha-trypsin inhibitor heavy chain H4(ITIH4), apoli-
poprotein E were decreased in OA serum samples. Alpha-2-macroglobulin,
ITIH4, kininogen-1 were related to the body's inﬂammatory reaction,
vitamin K-dependent protein S, apolipoprotein E were involved in cell
apoptosis , and alpha-2-macroglobulin, complement C3 participated in
immune response. Some studies indicated that alpha-2-macroglobulin is
related to the degradation of cartilage extracellular matrix. Some studies
found that alpha-2-macroglobulin, apolipoprotein E, Complement 3, gel-
solin, haptoglobin and kininogen-1 appearanced in synovial [[Unsup-
ported Character - ﬂ]]uid, and apolipoprotein E, alpha- 2-macroglobulin,
haptoglobin increased in synovial [[Unsupported Character - ﬂ]]uid from
OA compared with the health controls.
Conclusions: 1,This study successfully settled the serum comparative
proteomics technique of OA, combined the 2D-DIGE and MALDI-TOF-MS,
which provided a valuable method for screening and identiﬁcation of
disease related proteins; 2,This study found that alpha-2-macroglobulin,
gelsolin, vitamin K-dependent protein S, kininogen-1, complement C3
were increased, and haptoglobin, inter-alpha-trypsin inhibitor heavy chain
H4(ITIH4), apolipoprotein E were decreased in OA serum samples. 3,The
result of bioinformatics analysis indicated that the pathogenesis of oste-
oarthritis might be related to inﬂammation, immune or cell apoptosis;
4,Alpha-2-macroglobulin,apolipoprotein E,complement C3,gelso-
lin,haptoglobin,kininogen-1 might be utilized as potential biomarkers fordiagnosis or treatment of OA, they also provided the new clues for the
future study of the OA pathogenesis.
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356-373 ELISA, A MORE SENSITIVE SANDWICH ASSAY FOR DETECTING
AGGRECAN FRAGMENTS CLEAVED BY ADATMSS AT 373-374 SITE, IS
A POTENTIAL BIOMARKER FOR HUMAN JOINT DISEASES.
B. Wang 1, A.-C.B. Jensen 1, K.T. Ngo 1, Y. Ding 2, P. Chen 1, M.A. Karsdal 1,
Q. Zheng 2, P. Qvist 1. 1Nordic BioSci., Copenhagen, DENMARK; 2Nordic
BioSci. Beijing, Beijing, China
Purpose: Aggrecan degradation is believed to be a crucial process in joint
diseases such as OA and RA. The ADAMTSs cleavage site TEGE373-
374ARGS is a hot spot for investigation of aggrecan degradation. We have
developed a competitive ELISA AGNx1 for detecting fragments containing
neo-epitope NITEGE373, and a sandwich ELISA G1-373 for detecting
fragment containing both NITEGE373 and an epitope located in G1/G2
domain of aggrecan. There are disadvantages for the existing ELISAs:
lower sensitivity for the fragment in serum samples and unsatisﬁed
technical performance result for G1-373 with higher coefﬁcient of vari-
ation (CV) variation.
The aim of this study was to develop a sandwich ELISA 356-373 with
higher sensitivity detecting fragments containing NITEGE373.The ELISAs
were characterized and compared by using the Full Depth Cartilage (FDC)
explant culture model.
Methods: Full depth bovine cartilage (FDC) including all subpopulations of
chondrocytes from superﬁcial zone to the deep zone of the cartilage
explants was obtained from the joint of one to two-year- old calf. The
pieces (20-25mg) were placed in 96-well plate and incubate for 21 days at
37C with 5% CO2. Serum freemedium containing oncostatin M and tumor
necrosis factor (TNF) alpha were replaced every second or third day and
store at -20C before analysis by: (1) competitive NITEGE373 ELISA
(AGNx1) detecting aggrecan fragments containing neo-epitope
NITEGE373, (2) sandwich G1-373 ELISA detecting aggrecan fragments
containing both neo-epitope NITEGE373 and G1 domain, (3) sandwich
356-373 ELISA detecting fragments containing both neo-epitope
NITEGE373 and epitope 352TVQTVTW358 in interglobular domain (IGD).
Results: We found that: (1) aggrecanase-derived aggrecan fragments
containing NITEGE373 were dose-dependently released in the early (day
2-7 of culturing) and mid phase (day 9-14) into the supernatant from FDC
explants stimulated with catabolic cytokines. (2) The fragments released,
proﬁled by the three assays, were similar but different: the NITEGE373
competitive ELISA and the 356-373 sandwich ELISA showed two peak
releases. The G1-373 sandwich ELISA only showed one release. (3) The
release of NITEGE373 fragments detected by NITEGE373 competitive ELISA
or the 356-373 sandwich ELISA was delayed by MMPs inhibitor GM6001,
whereas the fragments release detected with G1-373 sandwich ELISA was
partially but signiﬁcantly inhibited by GM6001 (33% inhibition), indicating
that MMPs are involved in G1-373 ELISA-detecting fragment derivation.
(4) Higher sensitivity and better technical performance data was achieved
for the 356-373 ELISA compared to NITEGE373 competitive ELISA and G1-
373 ELISA, respectively. (5) 356-373 ELISA could be applied for human
samples testing with good dilution recovery, indicating its further poten-
tial clinical application for joint diseases as a biomarker.
Conclusions: We developed a new sandwich ELISA detecting the
ADAMTSs derived fragments containing neo-epitope NITEGE373 and
another epitope 352TVQTVTW358 in IGD. This ELISA is more sensitive
than the previous competitive NITEGE373 ELISA which are lack of sensi-
tivity for human samples test, and more technically robust than the G1-
373 ELISA which has weak stability. Its clinical application, i.e., patient
samples detection, will be investigated in the coming future.
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THE IDENTIFICATION AND DEVELOPMENT OF COMPETITION ELISA FOR
NEUTROPHILELASTASE-DERIVED LUBRICIN FRAGMENT: A POTENTIAL
BIOMARKER OF EARLY ARTICULAR CARTILAGEDEGRADATION
Y.He1,Q. Liu 2,Q. Zheng 2, B.Wang 1,M.A. Karsdal 1, A.-C. Bay-Jensen 1.1Nordic
BioSci. A/S, Herlev, DENMARK; 2Nordic BioSci. China, Beijing, China
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S90Purpose: Lubricin (aka. PG4, superﬁcial zone protein) is secreted by
synovial ﬁbroblast and chondrocyte of superﬁcial layer of articular carti-
lage, where it maintains a lubricated and friction-less surface. We specu-
lated that that degradation lubricin by neutrophil elastase whose
expression is up-regulated following inﬂammatory insults and the release
of these fragments into the synovial cavity might be an early biomarker of
joint diseases. We therefore set-out to develop an ELISA measuring
protease derived fragments of lubricin.
Methods: Human cartilage and synovial membrane were in vitro digested
by a variety of MMPs, aggrecanase, cysteine proteinase and serine
proteinase respectively, including MMP2, MMP12, MMP13, ADAMTS4,
ADAMTS5, Cathepsin B and Neutrophil Elastase. The proteolysis products
were analyzed by mass spectrometry and evaluated using the Mascot
database. A cleavage fragment (neoepitope) of lubricin was identiﬁed. A
peptidewas generated, which conjugated to KLH- and used as immunogen.
Six eight-week old Balb/C mice were immunized sequentially and the
immuno-reactivity towards the lubricin neoepitopewas tested after 3rd, 4th
and 5th immunization. Mice with best reactivity were selected and spleens
were isolated and fused with SP2/O cells. The hybridomas were subse-
quently cloned by classic limiting dilution method, and subclones were
produced. The best monoclonal antibody was selected based on following
criteria: speciﬁcity towards neoepitope using a speciﬁc peptide (positive
control), elongated peptide (negative control) and nonsense peptide
(negative control). Furthermore, the Mabs were tested for reactivity in
native samples, such as serum, urine, synovial ﬂuid and culture superna-
tants. A competition ELISA was developed using the best Mab with
following procedure: a 96-well streptavidin-coated plate was coated with
1ng/ml Biotin labeled lubricin neoepitope for 30 min at 20C, at 300 rpm.
The plate was then washed 5 times with standard wash solution. Standard
and samples were added 20ul/well, followed by the addition of 100ul/well
peroxidase labeled antibody and incubated onvernight (201 h) at 4C, at
300 rpm. After that, the wells were washed 5 times and incubated with
100ul/well TMB at 20C, at 300 rpm for 15 min. Then 100ul/well stop
solution was added and the colorimetric reaction was measured at 450nm
with reference at 650nm. The ELISAwas used to characterize the release of
the fragments from human cartilage explants.
Likewise, synovial ﬂuid samples from OA patients were measured (n¼15).
Results: A speciﬁc lubricin neoepitope with C-terminal cleavage site
generated by Neutrophil Elastase was identiﬁed by mass spectrometry.
Blasting results showed that it was speciﬁc for human lubricin. All mice had
strong immunization response to the neoepitope linked KLH-immunogen.
After serial subcloning, one antibody producing clone, Mab-13H1, with IgG
[[Unsupported Character - L]] isotype was obtained and characterized. It
had speciﬁc response to the speciﬁc peptide, but not toward the elongated
peptide. Thus the Mab-13H1 was speciﬁc for the cleavage site. The
competitiveELISA showedgood technical performance:1)measuring range
from 0.27ng/ml to 200ng/ml; 2) intra- and inter-assay CVs: 10% and 15%; 3)
Dilution recovery of human serum samples: 82.8%-112%; 4) interference:
blocked by adding liquid-II. The neoepitope was found in synovial ﬂuid of
patients with range from 1,16ng/ml to 23,042ng/ml (unadjusted values).
Conclusion: We identiﬁed and developed a new competitive ELISA for
measuring of lubricin neoepitope primarily from synovial membrane. We
found measurable amounts in synovial ﬂuid of RA patients, indicating that
this could be a novel biomarker of early cartilage loss.
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TWO NOVEL DIAGNOSTIC BIOMARKERS OF CARTILAGE DEGRADATION
AND CONNECTIVE TISSUE INFLAMMATION ARE PREDICTIVE OF
RADIOGRAPHIC DISEASE PROGRESSION
A.-C. Bay-Jensen 1, S. Wichuk 2, I. Byrjalsen 1, M.A. Karsdal 1,
W.P. Maksymowych 2. 1Nordic BioSci. A/S, Herlev, DENMARK; 2Div. of
Rheumatology, University of Alberta, AB, CANADAPredictive value for radiographic progression of serum C2M and C3M
High C2M (n¼94) High C3M (n¼
Positive predictive value 0.44 (0.27 - 0.62) 0.59 (0.41 - 0.7
Negative predictive value 0.70 (0.57 - 0.81) 0.57 (0.43 - 0.6Purpose: Cartilage degradation and inﬂammation of connective tissue are
key events in inﬂammatory and non-inﬂammaory arthropathies, such as
osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis
(AS). Presently there are no prognostic tools available for measuring these
tissue related processes, which are often the target of intervention.
Inﬂammation induces an increase in collagenases. An elevated level of
collagenases will lead to increased degradation of the disease affected
tissues, e.g. cartilage and synovial tissue. Type II collagen is the primary
protein component of cartilage and type III collagen is one of the major
proteins of many connective tissues (e.g. synovial membrane); thus they
are obvious targets for the action of collagenases. The objective of the
study was to investigate whether those fragments could be used as
predictive biomarkers of radiographic disease progression.
Method: Serum samples were collected from patient suffering from AS
(n¼124) at baseline and 2-3 month treatment follow-up. Standard AS
clinical outcome scores were collected: BASDAI (health questionnaire) and
mSASSS (radiographic scoring). Progressors were deﬁned as having new
vertebra syndesmophytes over a two year period. Serum levels of type II
collagen degradation was measured by the C2M competitive ELISA, and
type III collagen degradation by the C3M ELISA. Serum hsCRP was likewise
measured. Logistic regression and CART were used to analyze the prog-
nostic value of the markers individually or in combination.
Results: Both cartilage and connective tissue degradation fragments, C2M
and C3M, were signiﬁcantly elevated in AS patient serum samples
compared to healthy controls (p<0.0001). The area under the curves of
C2M and C3M, respectively, were 70% and 81% for AS. C3M correlated
signiﬁcantly with AS score BASDAI and mSASSS (p<0.01). C2M did not
show the same correlations. A combination of the two markers could
predict 80% of those who was deﬁned as progressors, with a negative
predictive value of 61%.
Conclusion:Present study is theﬁrst to showthat the twonovelbiomarkers
of cartilage andconnective tissuedegradation addadditional information to
the understanding of the diagnosis and progression of arthropathies. No
other clinical score or biomarker possesses these properties.
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GLA RICH PROTEIN (GRP) IS ASSOCIATED TO OSTEOARTHRITIS BEING
HIGHLY ACCUMULATED IN THE JOINT TISSUES AND SYNOVIAL FLUID
S.I. Cavaco 1, C.B. Viegas 1,2, R. Marta 1, R. Acácio 3, J. Silva 3, J.L. Morera 4,
A. Teixeira 4, E. Smit 5, M. Herfs 5, C. Vermeer 5, D.C. Simes 1,2. 1CCMAR,
Algarve Univ., Faro, PORTUGAL; 2GenoGla Diagnostics, Faro, PORTUGAL;
3 Faro Hosp., Dept. of Orthopedic and Traumathology, Faro, PORTUGAL;
4 Faro Hosp., Dept. of Anatomical Pathology, Faro, PORTUGAL; 5VitaK,
Maastricht Univ., Maastricht, NETHERLANDS
Purpose: The newly discovered Gla-rich protein (GRP) is a vitamin K-
dependent protein with high calcium-binding ability through its Gla
residues. It was recently shown to be highly expressed and accumulated in
rat cartilage and bone, and was suggested to be an important new player in
the complexity of phenotypes involving connective tissue mineralization.
With this work we aim to unveil the relationship between GRP and the
molecular mechanisms involved in cartilage degradation and calciﬁcation
associated with osteoarthritis (OA).
Methods: To investigate a possible involvement of GRP in OA processes we
have analyzed samples of synovial membrane, cartilage, subchondral bone
and synovial ﬂuid, collected from OA patients at the time of total knee
arthroplasty. Western blot and immunohistochemistry (IHC) techniques
were performed using polyclonal antibodies against total GRP (CTerm-
GRP) and the carboxylated form of GRP (anti-cGRP). Protein extracts from
cartilage and synovial ﬂuid were also analyzed using 2-D electrophoresis
and GRP was detected by Western blot. The presence of the four GRP
isoforms previously described in mouse was analyzed in human joint
tissues using speciﬁc primers.94) High hsCRP (n¼87) High C2M & high C3M (n¼33)
5) 0.33 (0.17 - 0.53) 0.80 (0.52 - 0.96)
9) 0.74 (0.60 - 0.84) 0.61 (0.36 - 0.83)
